Hazenberg, B. P. Et Al. 2006. Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial. Annual European Congress of Rheumatology (EULAR 2006) , (Amsterdam, Netherlands), 101.

Hazenberg, B. P., Hawkins, P. N., Butrimiene, I., Lesnyak, O., Livneh, A., Nasonov, E. L., ... Filipowicz-Sosnowska, A.(2006). Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial . Annual European Congress of Rheumatology (EULAR 2006) (pp.101). Amsterdam, Netherlands

Hazenberg, B. Et Al. "Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial," Annual European Congress of Rheumatology (EULAR 2006), Amsterdam, Netherlands, 2006

Hazenberg, B. P. Et Al. "Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial." Annual European Congress of Rheumatology (EULAR 2006) , Amsterdam, Netherlands, pp.101, 2006

Hazenberg, B. P. Et Al. (2006) . "Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial." Annual European Congress of Rheumatology (EULAR 2006) , Amsterdam, Netherlands, p.101.

@conferencepaper{conferencepaper, author={B. P. Hazenberg Et Al. }, title={Treatment for amyloid A (AA) amyloidosis with eprodisate disodium (NC-503): 2-year results of efficacy and safety from a multi-center international trial}, congress name={Annual European Congress of Rheumatology (EULAR 2006)}, city={Amsterdam}, country={Netherlands}, year={2006}, pages={101} }